Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardioversion of atrial fibrillation

G Y Lip1

  • 1University Department of Medicine, City Hospital, Birmingham, UK.

Postgraduate Medical Journal
|August 1, 1995
PubMed
Summary

Cardioversion for atrial fibrillation improves heart function and may lower stroke risk. This review clarifies electrical/pharmacological methods, drug use, and anticoagulant therapy timing for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

State of play and future direction with NOACs: An expert consensus.

Vascular pharmacology·2018
Same author

Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.

International journal of cardiology·2017
Same author

Reply to Jolobe

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

Clinical Stroke prevention in atrial fibrillation.

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

Short runs of atrial arrhythmia and stroke risk: a European-wide online survey among stroke physicians and cardiologists.

The journal of the Royal College of Physicians of Edinburgh·2016
Same author

'Patient choice' concept in AF ESC Guidelines: is the clinician giving up? Reply.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2013

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Atrial fibrillation (AF) management often involves cardioversion to restore normal heart rhythm.
  • Uncertainty exists regarding optimal cardioversion strategies, including drug choices and anticoagulation duration.
  • Improving cardiac performance and reducing thromboembolic risk are key goals of AF cardioversion.

Purpose of the Study:

  • To review current understanding of electrical and pharmacological cardioversion for atrial fibrillation.
  • To discuss the clinical effects of cardioversion.
  • To clarify the role of prophylactic anti-arrhythmic and anticoagulant therapy in AF cardioversion.

Main Methods:

  • Literature review of electrical and pharmacological cardioversion techniques for atrial fibrillation.
  • Analysis of clinical effects and outcomes associated with different cardioversion methods.
  • Evaluation of prophylactic anti-arrhythmic and anticoagulant therapy guidelines.

Main Results:

  • Cardioversion aims to improve cardiac function and reduce stroke risk in AF patients.
  • Both electrical and pharmacological cardioversion methods are available, each with specific considerations.
  • Appropriate use of anti-arrhythmic drugs and tailored anticoagulant therapy are crucial for successful and safe cardioversion.

Conclusions:

  • Cardioversion is a valuable strategy for managing atrial fibrillation.
  • Understanding the nuances of different cardioversion methods and adjunctive therapies is essential for clinicians.
  • Optimizing anti-arrhythmic and anticoagulant protocols enhances cardioversion efficacy and patient safety.

Related Experiment Videos